The study by Temma et al. focused on radiolabeling anti-MT1-mAb with [99mTc] to detect MT1-MMP, an enzyme with high expression on the surface of malignant tumor cells, which is suitable for a diagnostic target. This evidence concerns the gene MMP14 and neoplasm.